Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VCRA
501
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $29.1M | 0.04% |
635,837
+8,500
| +1% | +$379K |
|
502
Ironwood Pharmaceuticals
IRWD
$674M
| $28.9M | 0.04% |
2,209,553
-1,228,500
| -36% | -$15.9M |
|
503
TechnipFMC
FTI
$30.1B
| $28.8M | 0.04% |
3,826,700
-121,095
| -3% | -$871K |
|
504
Vishay Precision Group
VPG
$908M
| $28.8M | 0.04% |
827,863
+10,390
| +1% | +$377K |
|
505
Masco
MAS
$14.7B
| $28.8M | 0.04% |
518,095
-688,205
| -57% | -$40.8M |
|
506
First American
FAF
$7.56B
| $28.7M | 0.04% |
428,400
+110,500
| +35% | +$7.38M |
|
|
HOLI
507
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $28.7M | 0.04% |
1,387,770
-216,118
| -13% | -$3.95M |
|
|
CIO
508
DELISTED
City Office REIT
CIO
| $28.7M | 0.04% |
1,604,816
-150,666
| -9% | -$2.19M |
|
509
Chewy
CHWY
$9.2B
| $28.6M | 0.04% |
420,300
-41,700
| -9% | -$3.45M |
|
510
Tandem Diabetes Care
TNDM
$1.61B
| $28.6M | 0.04% |
239,546
+205,119
| +596% | +$22.6M |
|
511
Perion Network
PERI
$384M
| $28.6M | 0.04% |
1,648,993
-202,180
| -11% | -$3.85M |
|
512
FerroAtlántica
GSM
$818M
| $28.6M | 0.04% |
3,283,194
-149,800
| -4% | -$1.02M |
|
|
MGLN
513
DELISTED
Magellan Health Services, Inc.
MGLN
| $28.6M | 0.04% |
302,099
-32,700
| -10% | -$3.09M |
|
|
ELME
514
Elme Communities
ELME
$144M
| $28.5M | 0.04% |
1,153,500
-329,300
| -22% | -$8.1M |
|
515
Gaming and Leisure Properties
GLPI
$12.7B
| $28.5M | 0.04% |
615,830
+229,348
| +59% | +$10.9M |
|
516
PennyMac Financial
PFSI
$4.13B
| $28.5M | 0.04% |
466,000
+225,200
| +94% | +$14.3M |
|
517
EPAM Systems
EPAM
$5.24B
| $28.5M | 0.04% |
+49,900
| New | +$29.4M |
|
|
BCPC
518
Balchem Corp
BCPC
$5.65B
| $28.5M | 0.04% |
196,200
+5,000
| +3% | +$677K |
|
519
e.l.f. Beauty
ELF
$5.43B
| $28.4M | 0.04% |
978,500
-58,500
| -6% | -$1.67M |
|
|
NXRT
520
NexPoint Residential Trust
NXRT
$636M
| $28.4M | 0.04% |
458,413
-1,800
| -0.4% | -$110K |
|
521
Royalty Pharma
RPRX
$26.1B
| $28.3M | 0.04% |
783,600
-45,000
| -5% | -$1.75M |
|
522
UFP Technologies
UFPT
$2.48B
| $28.3M | 0.04% |
459,693
-10,680
| -2% | -$674K |
|
523
Antero Resources
AR
$11.3B
| $28.3M | 0.04% |
1,505,010
-1,352,590
| -47% | -$19.7M |
|
524
Stewart Information Services
STC
$2.07B
| $28.2M | 0.04% |
446,397
+18,500
| +4% | +$1.1M |
|
525
Sensata Technologies
ST
$6.61B
| $28.2M | 0.04% |
514,600
-118,100
| -19% | -$6.79M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.